These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 18347172)
21. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Bahl M; Ennis M; Tannock IF; Hux JE; Pritchard KI; Koo J; Goodwin PJ Breast Cancer Res Treat; 2005 Nov; 94(2):135-44. PubMed ID: 16261412 [TBL] [Abstract][Full Text] [Related]
22. Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer. Van Laere S; Beissbarth T; Van der Auwera I; Van den Eynden G; Trinh XB; Elst H; Van Hummelen P; van Dam P; Van Marck E; Vermeulen P; Dirix L Clin Cancer Res; 2008 Nov; 14(22):7452-60. PubMed ID: 19010862 [TBL] [Abstract][Full Text] [Related]
23. Body mass index and outcome after ventricular assist device placement. Musci M; Loforte A; Potapov EV; Krabatsch T; Weng Y; Pasic M; Hetzer R Ann Thorac Surg; 2008 Oct; 86(4):1236-42. PubMed ID: 18805168 [TBL] [Abstract][Full Text] [Related]
24. Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association. Majed B; Dozol A; Ribassin-Majed L; Senouci K; Asselain B Breast Cancer Res Treat; 2011 Apr; 126(3):729-38. PubMed ID: 20872242 [TBL] [Abstract][Full Text] [Related]
25. Multifocal breast cancer in women < or =35 years old. Litton JK; Eralp Y; Gonzalez-Angulo AM; Broglio K; Uyei A; Hortobagyi GN; Arun B Cancer; 2007 Oct; 110(7):1445-50. PubMed ID: 17676585 [TBL] [Abstract][Full Text] [Related]
26. Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points. Majed B; Moreau T; Asselain B; Breast Cancer Res Treat; 2009 May; 115(1):193-203. PubMed ID: 18546073 [TBL] [Abstract][Full Text] [Related]
27. The effect of obesity on survival in patients with ovarian cancer. Matthews KS; Straughn JM; Kemper MK; Hoskins KE; Wang W; Rocconi RP Gynecol Oncol; 2009 Feb; 112(2):389-93. PubMed ID: 19062080 [TBL] [Abstract][Full Text] [Related]
28. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Othman M; Kawar B; El Nahas AM Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231 [TBL] [Abstract][Full Text] [Related]
29. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy. Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M; Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948 [TBL] [Abstract][Full Text] [Related]
30. Body mass and mortality after breast cancer diagnosis. Whiteman MK; Hillis SD; Curtis KM; McDonald JA; Wingo PA; Marchbanks PA Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2009-14. PubMed ID: 16103453 [TBL] [Abstract][Full Text] [Related]
31. Body mass index in relation to ovarian cancer survival. Zhang M; Xie X; Lee AH; Binns CW; Holman CD Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1307-10. PubMed ID: 15894691 [TBL] [Abstract][Full Text] [Related]
32. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593 [TBL] [Abstract][Full Text] [Related]
33. Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy. van Roermund JG; Kok DE; Wildhagen MF; Kiemeney LA; Struik F; Sloot S; van Oort IM; Hulsbergen-van de Kaa CA; van Leenders GJ; Bangma CH; Witjes JA BJU Int; 2009 Aug; 104(3):321-5. PubMed ID: 19220264 [TBL] [Abstract][Full Text] [Related]
34. Impact of obesity on diagnosis and treatment of breast cancer. Deglise C; Bouchardy C; Burri M; Usel M; Neyroud-Caspar I; Vlastos G; Chappuis PO; Ceschi M; Ess S; Castiglione M; Rapiti E; Verkooijen HM Breast Cancer Res Treat; 2010 Feb; 120(1):185-93. PubMed ID: 19597985 [TBL] [Abstract][Full Text] [Related]
35. Body mass index and poststroke mortality. Olsen TS; Dehlendorff C; Petersen HG; Andersen KK Neuroepidemiology; 2008; 30(2):93-100. PubMed ID: 18309248 [TBL] [Abstract][Full Text] [Related]
36. Liver transplantation at the extremes of the body mass index. Dick AA; Spitzer AL; Seifert CF; Deckert A; Carithers RL; Reyes JD; Perkins JD Liver Transpl; 2009 Aug; 15(8):968-77. PubMed ID: 19642131 [TBL] [Abstract][Full Text] [Related]
37. Survival impact of integrative cancer care in advanced metastatic breast cancer. Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J Breast J; 2009; 15(4):357-66. PubMed ID: 19470134 [TBL] [Abstract][Full Text] [Related]
38. Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population? Pfitzenmaier J; Pritsch M; Haferkamp A; Jakobi H; Fritsch F; Gilfrich C; Djakovic N; Buse S; Pahernik S; Hohenfellner M BJU Int; 2009 Apr; 103(7):877-82. PubMed ID: 19007372 [TBL] [Abstract][Full Text] [Related]
39. Does obesity compromise survival in women with breast cancer? Carmichael AR; Bendall S; Lockerbie L; Prescott RJ; Bates T Breast; 2004 Apr; 13(2):93-6. PubMed ID: 15019687 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer. Parikh RR; Housman D; Yang Q; Toppmeyer D; Wilson LD; Haffty BG Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1056-63. PubMed ID: 18676094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]